In this digital transformation race sprung about by COVID-19, companies like IMAPAC have rapidly increased the use of digital tools to stay afloat during the pandemic. Revamping from having a portfolio that consisted… read more

INFOGRAPHIC OF THE WEEK In a recent market outlook analysis by Genetic Engineering & Biotechnology News, the APAC global cell and gene therapy space has been predicted to emerge as a major market.… read more

IMAPAC recently rounded up its “Corona360 In-Conversation” series of live moderated interviews. It brought together vaccine industry experts in lively, thought-provoking discussions on the challenges and possible solutions in the race to develop… read more

Excerpt Eli Lilly and Company have launched the Leonard Award, to acknowledge a diverse group of five individuals working to advance diabetes management through innovative thinking and novel approaches. Lilly will donate a… read more

Excerpt Bio-Thera Solutions, a biopharmaceutical company based in Guangzhou, China, has initiated the first Phase 3 study of a golimumab biosimilar in China and Eastern Europe, which is expected to enrol 598 subjects… read more

Excerpt Lonza and ValenzaBio have entered an agreement for the accelerated manufacturing of VB421, an anti-insulin-like growth factor 1 receptor (anti-IGF-1R) under evaluation for the treatment of thyroid eye disease (TED) and other… read more

Excerpt Theramex, a global speciality pharmaceutical company dedicated to women’s health, has signed an agreement with Enzene Biosciences Ltd., Pune, India, to register and commercialise denosumab for use in Europe, the UK, Switzerland,… read more

Aldevron, a leading global provider of high-quality plasmid DNA, mRNA and recombinant proteins used in vaccines, gene and cell therapy, gene editing and diagnostic applications, is being sold by EQT to Danaher Corporations… read more

Excerpt: Led by Casdin Capital, Sofinnova Partners, and an undisclosed investor, the €75 million ($90 million) Series A funding will help accelerate Mnemo Therapeutics’ development of its EnfiniT targeting and next generation chimeric… read more

A clinical trial was launched last year in Jakarta, Indonesia, after the COVID-19 occupancy rate in the city’s ICUs and mortality rate of critically ill COVID-19 pneumonia patients hit alarmingly high numbers. The… read more

The Phase 1 (Ph1), open-label study aims to evaluate the safety, tolerability and preliminary efficacy of pluripotent stem cell-derived dopaminergic neurons in patients with advanced Parkinson’s disease (PD), and has dosed its first… read more

Researchers at Vinmec Research Institute of Stem Cell and Gene Technology in Hanoi, Vietnam, conducted a randomized clinical trial examining the safety and therapeutic potential of autologous bone marrow stem cells, finding that… read more

COVAX has welcomed G7 leaders’ pledge to share these doses internationally in support of equitable access, building on the momentum of the G20 Global Health Summit and the Gavi COVAX AMC Summit. In… read more